z-logo
open-access-imgOpen Access
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa
Author(s) -
Síle F. Molloy,
Cecilia Kanyama,
Robert S. Heyderman,
Angela Loyse,
Charles Kouanfack,
Duncan Chanda,
Sayoki Mfinanga,
Elvis Temfack,
Shabir Lakhi,
Sokoine Lesikari,
Adrienne K Chan,
Neil Stone,
Newton Kalata,
Natasha Karunaharan,
Katherine M. Gaskell,
Mary Peirse,
Jayne Ellis,
Chimwemwe Chawinga,
Sandrine Sa’a Lontsi,
Jean-Gilbert Ndong,
Philip Bright,
Duncan Lupiya,
Tao Chen,
John Bradley,
Jack Adams,
Charles van der Horst,
Joep J. van Oosterhout,
Victor Sini,
Yacouba Njankouo Mapoure,
Peter Mwaba,
Tihana Bicanic,
David G. Lalloo,
Duolao Wang,
Mina C. Hosseinipour,
Olivier Lortholary,
Shabbar Jaffar,
Thomas S. Harrison
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1710922
Subject(s) - cryptococcal meningitis , antifungal , cryptococcosis , cryptococcus neoformans , meningitis , medicine , microbiology and biotechnology , biology , virology , immunology , human immunodeficiency virus (hiv) , pediatrics , viral disease
Cryptococcal meningitis accounts for more than 100,000 human immunodeficiency virus (HIV)-related deaths per year. We tested two treatment strategies that could be more sustainable in Africa than the standard of 2 weeks of amphotericin B plus flucytosine and more effective than the widely used fluconazole monotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom